newlogo1.jpg

Exhibit 99.1
Investor ContactMedia Contact
Olga Guyette, Director-Investor RelationsCarla Burigatto, VP-Communications
(781) 356-9763(781) 348-7263
olga.guyette@haemonetics.comcarla.burigatto@haemonetics.com

Haemonetics Reports 4th Quarter and Fiscal 2020 Results;
Provides Update on Business Continuity and Impacts from COVID-19

Boston, MA, May 5, 2020 - Haemonetics Corporation (NYSE: HAE) reported financial results for its fourth quarter and fiscal 2020, which ended March 28, 2020:
4th Quarter 2020Fiscal 2020
Revenue, decrease / increase$238 million, (4%)$988 million, 2%
Revenue increase (organic)1
1%6%
Earnings per diluted share$0.34$1.48
Adjusted earnings per diluted share$0.69$3.31
Cash flow from operating activities$46 million$158 million
Free cash flow before restructuring & turnaround2
$44 million$139 million
1Organic growth excludes the impact of currency fluctuation, fiscal 2019 OrthoPAT® revenue due to the product end of life in Hospital and certain strategic exits within our plasma liquids solutions business.
2Free cash flow before restructuring & turnaround does not include net cash proceeds of $15.0 million from the sale of the Company’s Braintree corporate headquarters in the second quarter of fiscal 2020.

Chris Simon, Haemonetics’ CEO, stated: “The positive finish to fiscal 2020 is evidence that the steps we have taken over the past four years have strengthened Haemonetics to improve our trajectory. Our response to the COVID-19 pandemic speaks to our commitment to support our healthcare customers. Our robust product portfolio and strong financial health position us to adapt to changing market conditions, drive results, complete our turnaround and accelerate transformational growth.”

GAAP RESULTS

Fourth quarter fiscal 2020 revenue was $238.5 million, down 4.3%, and fiscal 2020 revenue was $988.5 million, up 2.2%, compared with the same periods of fiscal 2019. Business unit revenue and growth rates compared with the same periods of the prior year were as follows:
1

The following information was filed by Haemonetics Corp (HAE) on Tuesday, May 5, 2020 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Haemonetics Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Haemonetics Corp.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Log in with your credentials

or    

Forgot your details?

Create Account